| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bausch & Lomb Corp | President, GPIC | Common Shares, No Par Value | 90,649 | $1,658,876 | $18.30 | 27 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BLCO | Bausch & Lomb Corp | 26 Feb 2026 | 2 | -$91,902 | 4 | President, GPIC | 02 Mar 2026, 18:03 |
| BLCO | Bausch & Lomb Corp | 25 Feb 2026 | 1 | $0 | 4 | President, GPIC | 27 Feb 2026, 16:24 |
| BLCO | Bausch & Lomb Corp | 24 Apr 2025 | 1 | -$54,921 | 4 | Officer | 25 Apr 2025, 16:06 |
| BLCO | Bausch & Lomb Corp | 26 Feb 2025 | 2 | $0 | 4 | Officer | 28 Feb 2025, 16:29 |
| BLCO | Bausch & Lomb Corp | 23 Dec 2024 | 1 | -$45,003 | 4 | Officer | 26 Dec 2024, 16:19 |
| BLCO | Bausch & Lomb Corp | 24 Apr 2024 | 1 | -$58,751 | 4 | Officer | 26 Apr 2024, 16:10 |
| BLCO | Bausch & Lomb Corp | 28 Feb 2024 | 2 | $0 | 4 | Officer | 01 Mar 2024, 16:35 |
| BLCO | Bausch & Lomb Corp | 24 Apr 2023 | 1 | $0 | 4 | The Reporting Person's title as an officer of the Issuer is President, Ophthalmic Pharmaceuticals. | 26 Apr 2023, 17:22 |
| BLCO | Bausch & Lomb Corp | 24 Apr 2023 | 0 | $0 | 3 | Officer | 26 Apr 2023, 17:14 |